The contract manufacturing organisation’s (CMO) plant, in Norwood, New Jersey, houses a range of spray drying technologies including a lab-scale Buchi B-290 for proof-of-concept studies and a Niro Mobile Minor 2000 for larger scale projects.
PSD said the unit will provide development-stage capacity for customers in the pharmaceutical, cosmetic and food supplement industries with subsequent commercial-scale production being provided by a Swiss CMO partner.
Spray-drying, the technique of converting liquid active pharmaceutical ingredients (APIs) to solids with price morphological control, has been something of a hot topic for the contract manufacturing sector in recent months.
PSD capacity expansion follows similar moves by Hovione, PharmaForm and GEA Niro to build in this area.